Americord Improves Cord Blood Collections
An abstract related to the development of CordAdvantage (our proprietary cord blood collection method) written by Americord’s Executive Medical Director Dr. Robert Dracker was recently published in “Blood”, a weekly medical journal published by the American Society of Hematology. CordAdvantage has shown promise in allowing doctors to collect far more hematopoietic cells by collecting the remaining stem cells in the placental blood. Studies have demonstrated that placenta cord blood contains significantly more stem cells than umbilical cord blood alone does, which makes it a valuable source of stem cells. Having more stem cells available in the event they are needed for medical treatment is directly correlated to an increase in patients’ survival rate. See our recent press release about CordAdvantage here.